Literature DB >> 231950

Serum lipoprotein lipids after gemfibrozil treatment.

P Schwandt, P Weisweiler, G Neureuther.   

Abstract

The changes of serum lipoprotein lipids including the phospholipids of twelve hyperlipoproteinemic patients were studied after a four weeks treatment with 1200 mg/day gemfibrozil. There was a decrease of all VLDL lipids as well as of LDL and HDL triglycerides and an increase of HDL cholesterol. The phospholipids were influenced in different directions, particularly their concentration in the HDL was constant. The LDL/HDL lipid ratios remained elevated after gemfibrozil. To evaluate the effect of a hypolipidemic drug in more detail, the analysis of the complete lipoprotein lipid moiety and the ratios within and between the lipoproteins would be helpful.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 231950

Source DB:  PubMed          Journal:  Artery        ISSN: 0098-6127


  2 in total

1.  Gemfibrozil absorption and elimination in kidney and liver disease.

Authors:  H Knauf; E U Kölle; E Mutschler
Journal:  Klin Wochenschr       Date:  1990-07-05

Review 2.  Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia.

Authors:  P A Todd; A Ward
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.